Cystatin-C versus Creatinine-Based eGFR in Bardet-Biedl Syndrome: Implications for Chronic Kidney Disease Detection
This study demonstrates that in pediatric patients with Bardet-Biedl syndrome, cystatin-C-based eGFR identifies significantly more cases of chronic kidney disease than creatinine-based estimates, particularly in females, suggesting that routine reliance on serum creatinine alone may underestimate kidney impairment in this population.